Chotai Silky, Medhkour Azedine
Division of Neurosurgery, Department of Surgery, University of Toledo Medical Center, Toledo, USA.
Division of Neurosurgery, Department of Surgery, University of Toledo Medical Center, Toledo, USA.
Clin Neurol Neurosurg. 2014 Oct;125:182-8. doi: 10.1016/j.clineuro.2014.07.027. Epub 2014 Aug 12.
Chiari malformation-I (CM) is one of the most controversial entities in the contemporary neurosurgical literature. Posterior fossa decompression (PFD) is the preferred treatment for CM with and without syringomyelia. A variety of surgical techniques for PFD have been advocated in the literature. The aim of this study was to evaluate our results of surgically treated patients for CM-I with and without syringomyelia; using extradural dura-splitting and intradural intraarachnoid techniques.
A retrospective review of the medical records of all the patients undergoing PFD was conducted. Symptomatic patients with tonsillar herniation≥3-mm below the foramen magnum on neuroimaging, and CSF flow void study demonstrating restricted or no CSF flow at the craniocervical junction, were offered surgical treatment. In patients without syringomyelia, extradural decompression with thinning of the sclerotic tissue at the cervicomedullary junction and splitting of outer dural layer was performed. In patients with syringomyelia, the dura was opened and an expansile duraplasty was performed.
The mean age of 8 males and 34 females was 33.8 years (range, 16-58 years). Headache (39/41; 95%), and/or tingling and numbness (17/41; 42%) were the most common presenting symptoms. The syrinx was associated with CM-I in 5/41 (12%) patients. PFD without durotomy was performed in 29/41 (73%) patients. The mean duration of preoperative symptoms was significantly longer in duraplasty group (4.6 versus 1.7 years, P=0.005, OR=0.48, CI=0.29-0.8). The use of duraplasty was significantly associated with presence of complications (P=0.004, OR=0.5, CI=0.3-0.8) and longer duration of hospital stay (P=0.03, OR=2.7, CI=1.1-6.8). The overall complication rate was 6/41(15%) patients. The overall improvement rate was evident in 84% (36/41); 12% (5/41) were stable; and 5% (2/41) had worsening of symptoms. The history of prior CM decompression was associated with unfavorable outcomes (P=0.04, OR=14, CI=1.06-184). One patient experienced recurrence one year after the PFD with duraplasty.
The present study reports favorable surgical outcomes with extra-dural decompression of the posterior fossa in patients CM-I without syringomyelia. For patients with syringomyelia and history of prior PFD, intradural intra-arachnoid decompression is required. The prior history of decompression was associated with unfavorable outcomes. The use of duraplasty was associated with longer duration of hospital stay and higher complication rate. Further large cohort prospective study is needed to provide any recommendation on the indication of intra or extradural decompression for a given CM-I patient.
Chiari畸形I型(CM)是当代神经外科文献中最具争议的病症之一。后颅窝减压术(PFD)是治疗伴有或不伴有脊髓空洞症的CM的首选方法。文献中提倡多种PFD手术技术。本研究的目的是评估我们采用硬脑膜外硬脑膜劈开术和硬脑膜内蛛网膜下腔技术治疗伴有或不伴有脊髓空洞症的CM-I患者的结果。
对所有接受PFD的患者的病历进行回顾性分析。神经影像学显示扁桃体疝出至枕大孔以下≥3mm且脑脊液流动间隙研究显示颅颈交界处脑脊液流动受限或无脑脊液流动的有症状患者接受手术治疗。对于无脊髓空洞症的患者,进行硬脑膜外减压,同时使颈髓交界处的硬化组织变薄并劈开硬脑膜外层。对于有脊髓空洞症的患者,打开硬脑膜并进行扩大硬脑膜成形术。
8名男性和34名女性的平均年龄为33.8岁(范围16 - 58岁)。头痛(39/41;95%)和/或刺痛与麻木(17/41;42%)是最常见的首发症状。5/41(12%)的患者脊髓空洞症与CM-I相关。29/41(73%)的患者未进行硬脑膜切开的PFD。硬脑膜成形术组术前症状的平均持续时间明显更长(4.6年对1.7年,P = 0.,OR = 0.48,CI = 0.29 - 0.8)。硬脑膜成形术的使用与并发症的发生显著相关(P = 0.004,OR = 0.5,CI = 0.3 - 0.8)以及住院时间延长(P = 0.03,OR = 2.7,CI = 1.1 - 6.8)。总体并发症发生率为6/41(15%)的患者。84%(36/41)的患者有明显改善;12%(5/41)病情稳定;5%(2/41)症状恶化。既往CM减压史与不良预后相关(P = 0.04,OR = 14,CI = 1.06 - 184)。一名患者在进行硬脑膜成形术的PFD术后一年复发。
本研究报告了对无脊髓空洞症的CM-I患者进行后颅窝硬脑膜外减压术的良好手术结果。对于有脊髓空洞症和既往PFD史的患者,需要进行硬脑膜内蛛网膜下腔减压术。既往减压史与不良预后相关。硬脑膜成形术的使用与住院时间延长和更高的并发症发生率相关。需要进一步的大型队列前瞻性研究,以针对特定的CM-I患者提供关于硬脑膜内或硬脑膜外减压适应症的任何建议。